UK pharmaceutical company GlaxoSmithKline plc (LON:GSK) on Monday announced that it will invest GBP 50 million (USD 68.4m/EUR 58.3m) in new wind and solar farms to power its factories, as part of the sector-wide commitment to reach net zero carbon emissions by 2050.